Protagenic Therapeutics, Inc.\new (PTIX) Common Equity (2013 - 2026)
Protagenic Therapeutics, Inc.\new (PTIX) posted Common Equity of $1.72 million for fiscal Q1 2027 (quarter ended Jun 30, 2026), compared with -$3.97 million a year earlier and down 34.2% from the prior quarter.
Powered by 
Analysis
Protagenic Therapeutics, Inc.\new (PTIX) Common Equity (2013 - 2026) Analysis & Trends
At the end of FY2026 (ended Mar 31, 2026), Protagenic Therapeutics, Inc.\new's Common Equity came in at $2.62 million.
- Annual Common Equity shows a five-year compound annual growth rate of -23.4% (FY2021 to FY2026).
- In prior fiscal years, Protagenic Therapeutics, Inc.\new's Common Equity was -$4.95 million in FY2025, -$3.32 million in FY2024, $3.67 million in FY2023 (-47.0%) and $6.92 million in FY2022 (-30.4%).
- Quarterly Common Equity has run from a low of -$4.95 million in fiscal Q4 2025 to a high of $2.62 million in fiscal Q4 2026 over five years.
- According to Business Quant data, Common Equity for the three prior fiscal quarters was $2.62 million (Q4 2026), -$2.39 million (Q3 2026) and -$4.7 million (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,166.78 Bn | 1,135.37 Bn | 19.71 Bn | 33.88 Bn |
| 2 | Johnson & Johnson | 635.34 Bn | 553.86 Bn | 17.26 Bn | 84.97 Bn |
| 3 | AbbVie | 503.48 Bn | 476.60 Bn | 12.70 Bn | -5.94 Bn |
| 4 | Merck | 377.08 Bn | 331.46 Bn | 12.21 Bn | 41.98 Bn |
| 5 | Novartis Ag | 304.13 Bn | 268.12 Bn | 11.24 Bn | 41.95 Bn |
| 6 | Astrazeneca | 267.48 Bn | 241.16 Bn | 12.86 Bn | 50.37 Bn |
| 7 | Amgen | 241.75 Bn | 197.15 Bn | 7.24 Bn | 11.69 Bn |
| 8 | Gilead Sciences | 194.09 Bn | 168.29 Bn | 6.22 Bn | 11.83 Bn |
| 9 | Pfizer | 172.59 Bn | 119.24 Bn | 10.94 Bn | 85.49 Bn |
| 10 | Protagenic Therapeutics, Inc.\new | 1.38 Mn | 1.38 Mn | - | 1.72 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.72 Mn |
| Mar 31, 2026 | 2.62 Mn |
| Dec 31, 2025 | -2.39 Mn |
| Sep 30, 2025 | -4.70 Mn |
| Jun 30, 2025 | -3.97 Mn |
| Mar 31, 2025 | -4.95 Mn |
| Dec 31, 2024 | -3.32 Mn |
| Sep 30, 2024 | -2.47 Mn |
| Jun 30, 2024 | -1.75 Mn |
| Mar 31, 2024 | -1.79 Mn |
| Dec 31, 2023 | 3.67 Mn |
| Sep 30, 2023 | 4.15 Mn |
| Jun 30, 2023 | 5.41 Mn |
| Mar 31, 2023 | 6.41 Mn |
| Dec 31, 2022 | 6.92 Mn |
| Sep 30, 2022 | 7.38 Mn |
| Jun 30, 2022 | 8.26 Mn |
| Mar 31, 2022 | 8.72 Mn |
| Dec 31, 2021 | 9.94 Mn |
| Sep 30, 2021 | -10.37 Mn |
API Access
Protagenic Therapeutics, Inc.\new Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=PTIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "PTIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=PTIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();